Management of fatty acid oxidation disorders: A survey of current treatment strategies

Journal of the American Dietetic Association

Volumn 102, Issue 12, 2002, Pages 1800-1803

  Solis, Java O ^a,b   Singh, Rani H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SARAH LAWRENCE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG CHAIN ACYL COENZYME A DEHYDROGENASE; PALMITOYL COENZYME A HYDROLASE; VERY LONG CHAIN FATTY ACID; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACETYL COENZYME A ACYLTRANSFERASE; ENOYL COENZYME A HYDRATASE; FATTY ACID OXIDATION COMPLEX; ISOMERASE;

DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; EVALUATION; FATTY ACID OXIDATION; FATTY ACID OXIDATION DISORDER; HEALTH SURVEY; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; NUTRITION; PATIENT CARE; QUESTIONNAIRE; REVIEW; STANDARDIZATION; TANDEM MASS SPECTROMETRY; ADULT; ARTICLE; CHILD; DIET THERAPY; INFANT; METABOLIC DISORDER; METABOLISM;

3-HYDROXYACYL COA DEHYDROGENASES; ACETYL-COA C-ACYLTRANSFERASE; ADULT; CARBON-CARBON DOUBLE BOND ISOMERASES; CHILD; ENOYL-COA HYDRATASE; HUMANS; INFANT; METABOLIC DISEASES; QUESTIONNAIRES; RACEMASES AND EPIMERASES;

EID: 0036884407     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(02)90386-X     Document Type: Article

References (24)

1. Hale DE, Bennett MJ. Fatty acid oxidation disorders: A new class of metabolic disease. J Pediatr. 1992;121:1-11.
2. Quintana LP, Crespo PS. Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders. An Esp Pediatr. 2001;55(6):524-534.
3. Wang SS, Fernhoff PM, Hannon WH, Khoury MJ. Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med. 1999;1(7):332-339.
4. Rinaldo P, Matern D. Fatty acid oxidation disorders. Annu Rev Physiol. 2002;64:477-502.
5. Neely JR, Morgan ME. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 1974;36:413-459.
6. Abdenur JE, Chamoles NA, Specola N, Schenone AB, Jorge L, Guinle A, Bernard C, Levandovskiy V, Fusta M, Lavorgna S Multiple Acyl-COA-Dehydrogenase deficiency (MADD): Use of Acylcarnitines and fatty acids to monitor the response to dietary treatment. Pediatr Res. 2001;50:61-66.
7. Hayde M, Widhalm K. Effects of cornstarch treatment in very young children with Type I Glycogen Storage Disease. Eur J Pediatr. 1990;149:630-633.
8. Fernandes J, Smit GPA. The Glycogen-Storage Diseases. In: Fernandes J, Saudubray JM, Van den Berghe C, eds. Inborn Errors of Metabolic Diseases, Diagnosis and Treatment. 3rd ed. New York: Springer-Verlag; 2000:86-101.
9. Breemer J. Carnitine-Metabolism and functions. Physiol Rev. 1983;63(4):1420-1480.
10. Treem WR, Stanley CA, Goodman SI. Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Metabolic effects and therapeutic efficacy of long-term L-Carnitine supplementation. J Inherit Metab Dis. 1989;12:112-119.
11. Kerner J, Hoppel C. Genetic disorders of carnitine metabolism and their nutritional management. Annu Rev Nutr. 1998;18:179-206.
12. Chalmers RA, Roe CR, Stacey TE, Hoppel CL. Urinary excretion of L-Carnitine and acylcarnitines by patients with disorders of organic acid metabolism: Evidence tor secondary insufficiency of L-Carnitine. Pediatr Res. 1984;18(12):1325-8.
13. Green A. Possible deleterious effect of L-Carnitine supplementation in a patient with mild multiple Acyl-CoA Dehydrogentation Deficiency (Ethylmalonic-adipic Aciduria). J Inher Metab Dis. 1991;14:691-697.
14. Przyremble H. Therapy of mitochondrial disorders. J Inher Metab Dis. 1986;10:129-146.
15. Shannon DW, Wolfe GS. Carnitine deficiency: A missed diagnosis. J Care Manag. 1997;3:2-8.
16. Glasgow A, Engel AG, Bier DM, Perry LW, Dickie M, Todaro J, Brown BI, Utter MF. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and Long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res. 1980;17:319-326.
17. Nyhan WL, Ozand PT. Disorders of Fatty Acid Oxidation. In: Atlas of Metabolic Diseases. 1st ed. London, UK: Chapman and Hall Medical; 1998:223-230.
18. Pollit RJ. Disorders of Mitochondrial Long-Chain Fatty Acid Oxidation. J Inherit Metab Dis. 1995;18:473-490.
19. Mead Johnson Nutritionals, Pediatric Products Handbook. Evansville, IN: Mead Johnson; 1995.
20. Glasgow AM, Eng G, Engel AG Systemic carnitine deficiency simulating recurrent Reye Syndrome. J Pediatr. 1980;96(5):889-891.
21. Singh RH. Dietary Management of Fatty Acid Oxidation Defects. Eighth International Congress of Inborn Errors of Metabolism. September 2000. Cambridge, UK (oral presentation).
22. Gillingham M, VanCalcar S, Ney D, Wolff J, Harding C. Dietary management of Long-Chain 3 Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHADD). A case report and survey. J Inherit Metab Dis. 1999;22:123-131.
23. Holman RT. Biological activities of and requirements for polyunsaturated acids. In: Progress in the Chemistry of Fats and Other Lipids. Vol 9. New York: Peragon Press; 1970:607-682.
24. Acosta PB, Yannicelli S. The Ross Metabolic Formula System Nutrition Support Protocols. Columbus, OH: Ross Products Divisions; 1997.